




'Member states must forbid the computerized processing
of health related data without the relevant person's free,
explicit and written consent.'
Disclosure of data on personal matters, racial or ethnic
origins, sexual life, political, philosophical or religious
opinions and mutual insurance relationships is prohibited.7
What protective measures
should be introduced?
1. Ethical codes of conduct for every operator/person
involved in the processing of data.
2. Maximum control of his own personal data by the
individual. The individual must: (J) be aware of the mere
existence cif a databank containing his personal details;
(if) be aware of the aims of processing the specific data;
(iif) have access to the data; ljv) have access to the names of
all people who have had access to his personal data; and
(v) be able to negotiate the alteration or deletion of specific
data.'
Conclusion
South Africa falls far behind international measures to
protect personal medical data. Currently, there is no specific
legislation to protect the individual's right to informational
self-determination. Processing clerks at hospitals and non-
treating physicians have free access to personal medical
data. No codes of conduct exist for the management and
control of computerised medical data. Private physicians
and their receptionists electronically communicate private
medical data to medical aid schemes, laboratories and the
like, with no guarantee that such data will not be divulged to
unauthorised third parties.
It is suggested that legislation for the protection of
personal data be given higher priority. In the interim,
physicians, hospitals and supplementary health services are
encouraged to take all reasonable steps to prevent
unauthorised disclosure and access to the individual's
personal data.
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Characterisation of penA
and tetM resistance genes
of Neisseria gonorrhoeae




L. J. Chalkley, S. van Vuuren, R. C. Ballard, P. L. Botha
Objective. To investigate penA and tetM resistance gene
variation of Neisseria gonorrhoeae in order to define gene
types for epidemiological monitoring and resistance
development.
Design. Isolates of N. gonorrhoeae which were
susceptible and resistant to penicillin and/or tetracycline
were selected. Strains comprised South African isolates
(22 from Bloemfontein, 13 from Transvaal, 20 from the
Cape) and 15 Botswana and 4 Namibia isolates. The penA
genes (2 kb) of a,1I strains and tetM genes (765 bp) of 11
high-level tetracycline-resistant strains were amplified and
restricted with Hpall.
Resuits and conclusions. Twelve different Hpall
fingerprint patterns were obtained from the 74 isolates
analysed for penicillin-binding protein (PBP) 2 gene (penA)
alterations. Focusing on the transpeptidase domain, 25
isolates (3 whole gene patterns, minimal inhibitory
concentrations (MICs) ~ 0,03 - 0,125 ~g/ml) had restriction
sites equivalent to those previously described for a
susceptible strain. Of the remaining 9 PBP 2 'gene groups,
25 strains fell into a designated group E. Penicillin/
penicillin + clavulanic acid MICs determined on these
group E isolates gave a range of 0,125 - 2,0 ~g/ml,
although MICs against 4 strains were ~ 0,03 ~g/ml. MICs
of penicillin/penicillin + c1avulanic acid for the 24 isolates
that contained altered PBP 2 transpeptidase gene regions
not designated group E were only ~ 0,03 - 0,125 ~g/ml.
The lack of a Hpall restriction site at nucleotide 1934 in
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the PBP 2 gene of group E strains was indicative of a
small terminal region of N. cinerea DNA. This gene block,
which was found in all the southern African areas studied,
appears to predispose isolates to increased penicillin
resistance. The 25,2 MDa conjugative plasmid carrying the
tetM resistance determinant was readily demonstrated in
11 Botswana! Namibia isolates exhibiting high-level
resistance to tetracycline (MICs ? 16 IJg/ml). The tetM
gene was shown to be of the American type.
S Afr Med J 1995; 85: 776-780.
Gonorrhoea is one of the most prevalent sexually
transmitted diseases, and causes serious complications if it
goes undetected or is incorrectly treated. Continued
surveillance of antibiotic resistance patterns and the specific
resistance determinants involved is required, as effective
treatment is often dependent on all isolates of Neisseria
gonorrhoeae's being susceptible to proposed antibiotic
regimens in a particular geographical area. Chromosomally
mediated 13-lactam resistance in N. gonorrhoeae is due to
alterations in binding affinity of penicillin-binding proteins
(PBPs) 1 and 2.'2 Studies have shown that alterations to
PBP 2 genes as a result of an Asp-345A insertion combined
with mutations and/or acquisition of resistant gene blocks
from commensal Neisseria species are responsible for
increased penicillin resistance.'" Because /If. gonorrhoeae
possess mosaic PBP 2 genes, there may be sufficient gene
variability to apply restriction fragment length polymorphism
(RFLP) analysis to group isolates for epidemiological
purposes as recently applied to group clinical isolates of
N. meningitidis.5-7 In addition, via the direct study of PBP 2
genes, RFLP grouping may correlate directly with increased
resistance to other 13-lactam antibiotics. Although
tetracycline is not the antibiotic of choice for the treatment
of N. gonorrhoeae in South Africa it is used throughout
central Africa as it is relatively inexpensive and is effective
against Chlamydia tiachomatis. Tetracycline resistance in
N. gonorrhoeae can be chromosomally or plasmid-
mediated.· Chromosomal resistance gives rise to low-level
resistance while N. gonorrhoeae that have acquired a 25,2
MDa conjugative plasmid carrying the tetM determinant
exhibit high levels of resistance minimal inhibitory
concentrations (MICs) ? 16 IJg/ml).s·lO High-level
tetracycline-resistant strains were first reported in the USA in
1985" and subsequently spread throughout Europe and
central Africa. 12·15 Two tetM genes have been described-
the American and the Dutch types, which are thought to
have different origins. 16
This study investigates penicillin- and tetracycline-




Isolates of N. gonorrhoeae that were susceptible and
resistant to penicillin and/or tetracycline were selected from
areas in southern Africa. The strains comprised the following
.South African isolates: 22 frqm Bloemfontein, 1994, 13 from
Transvaal, 1993 and 20 from the Cape, 1994, as well as'15
strains from Gaborone, Botswana and 4 from Windhoek,
Namibia, 1993. All isolates were identified as N.
gonorrhoeae by Gram stain and conventional biochemical
methods - oxidase positivity and ability to produce acid
from glucose but not maltose, sucrose or lactose.'7.,. Beta-
lactamase production was detected by means of the
chromogenic cephalosporin (Nitrocefin, Oxoid) method."
The Bloemfontein, Cape and Transvaal strains were selected
mainly form 13-lactamase-negative isolates so as not to
complicate detection of chromosomally mediated penicillin
resistance. The Botswana and Namibia isolates were
selected to provide a range of tetracycline-resistant strains.
Antibiotic susceptibility tests
Standard reference powders were obtained from the
following sources: penicillin (Glaxo), tetracycline (8pjohn)
and clavulanic acid (Beecham). MICs were determined by
the agar dilution method,'O using dextrose starch a,gar
(Oxoid) supplemented with 1% (v/v) IsoVitaleX (Bf3L) and 5%
(v/v) laked horse blood. Plates were inoculated with 1 x 1er
colony-forming units per millilitre using a Steers Multipoint
replicator (Mast Laboratories), and were incubated at 35°C
for 24 hours in an atmosphere containing 5 - 10% CO2 ,
Fixed clavulanic acid concentrations of 4 IJg/ml in
combination with serial dilutions of penicillin were tested on
13-lactamase-positive strains. The World Health Organisation
reference strains A - E were used as controls.
DNA fingerprinting of PBP 2 genes
Cells from half a chocolate agar plate showing confluent
growth were resuspended in 0,5 ml buffer (0,5 mM tris-HCI,
20 mM EDTA, pH 7,4) containing 25 IJg of lysozyme. After 10
minutes at room temperature 0,5 ml of 2% Triton-X 100 and
12,5 IJg of Proteinase K (Boehringer) were added. The penA
genes were amplified using 5 IJI of crude cell extract in a
final reaction volume of 100 IJI. Amplification of the entire
PBP 2 gene (2 kb) was performed by polymerase chain
reaction (PCR) using previously described primers GC11 and
GCdown3.s.2' For amplification of the transpeptidase domain
of the penA gene (1,4 kb), primer GC11 was replaced with
primer GCup2.21 Amplification was carried out for 20 cycles;
95°C, 1 minute; 52°C, 2 minutes; 72°C, 3 minutes. PCR
products were restricted with Hpall and fragments 'end-
labelled with FP] dCTP (Amersham) as described
previously.s Samples were run on a 6% nondenaturing
polyacrylamide gel and alltoradiographed. After Hpall
digestion of pBR322 DNA, fragments were end-labelled with
[32P] dCTP and used as a size marker.
Plasmid analysis
Hi.gh-Ievel tetracycline-resistant strains were grown on GC
agar base (Difco) supplemented with 1% (v/v) IsoVitaleX that
contained 10 IJg/ml tetracycline. Cells harvested from 1 - 3
plates (approximately 1 x 1D· CFU/ml) were suspended in
cell resuspension solution provided in the Magic Miniprep
DNA Purification System (Promega). Plasmids were isolated
according to the Magic Miniprep (Promega) protocol with
the exception that 4 IJg of mutanolysin (Sigma) and 10 IJg
lysozyme (Sigma) were added to aid lysis. Plasmid
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preparations were electrophoresed on 0,7% agarose gels
and visualised by staining with ethidium bromide. The
'13-lactamase plasmids were sized using a supercoiled DNA
ladder (Promega).
TetM gene analysis
Cells were.harvested from confluent growth on half an
IsoVitaleX GC agar base plate containing 10 ~g/ml
tetracycline. Cells were resuspended and lysed as described
above for PBP 2 gene amplification. The tetM genes were
amplified with 5 ~I of crude cell extract in a final reaction
volume of 100 ~1. PCR conditions using primers A and B
with thermal cycling: 30 cycles; 94°C, 30 seconds; 50°C, 20
seconds; 72°C, 20 seconds were employed as previously
described. tO PCR products were restricted with Hpall, and
the fragments generated were separated on a 2% agarose
gel and visualised using ethidium bromide. >..DNA was used
as a Hpall restriction enzyme control and DNA MWM V
(Boehringer) as a size marker. American (strain 6418) and
Dutch (strain 2903) type tetM genes were amplified and
restricted for comparative purposes.
Results
The MICs of penicillin for the southern African isolates
studied are shown in Tables I and 11. As the majority of
Botswana and Namibia isolates were resistant to penicillin
because of 13-lactamases, MICs of penicillin + clavulanic
acid were also determined for 13-lactamase-producing
. isolates in order to detect reduced susceptibility mediated
by underlying PBP alterations. All the isolates were screened
Table I. Details of the N. gonorrhoeae isolates from South Africa
for high-level tetracycline resistance with plates containing
10 ~g/ml tetracycline. Only Botswana and Namibia strains
exhibited high-level tetracycline resistance (Table 11).
Representative Hpall-restricted PBP 2 gene fingerprint
profiles of isolates from the different areas studied are
shown in Fig. 1. Major groups were designated A - E with
some subgroups defined in groups A, Band C. The PBP 2
fingerprint groups assigned to all the strains studied are
shown in Tables I and 11. The A1 fingerprint group contains
the same restriction fragments that would be generated
from the reported sequence of a susceptible isolate.
N. gonorrhoeae LM306!t Fingerprint groups A2 and A3
showed alterations upstream of the transpeptidase domain;
penicillin MICs of these 25 strains were:;;.; 0,03 - 0,125
~g/ml. Penicillin/penicillin + c1avulanic acid MICs of strains
in groups B, C and D also showed MICs in the range of
:;;.; 0,03 - 0,125 ~g!ml whereas 20 of 24 group E strains On
which penicillin/penicillin + c1avulanic acid MICs were
performed showed MICs of 0,125 - 2,0 ~g/ml. It should be
noted that four group E strains showed penicillin MICs
:;;.; 0,03 ~g/ml. Analysing the Hpall restriction sites within the
transpeptidase domain of the PBP 2 gene with published
sequences of penicillin-susceptible and resistant
N. gonorrhoeae isolates:2t the major alterations in restriction
sites for groups C, D and E were present in the terminal
450 bp region and those of group B upstream of the
terminal 450 bp area. Fingerprint patterns specific to the
transpeptidase domain of groups C1, D and E are shown in
Fig. 1. Group D patterns appeared comparable to strain
USACDC84060418,' which contains a N. flavescens and a
N. cinerea insertion. Group E patterns were comparable with
strain USACDC77-124615: and lacked a Hpall restriction
site at nucleotide 1934. This suggests a small terminal
Bloemfontein (N = 22)
Pen MIC Pen +
13-lact. (~g/ml) c1av*









































































































PBP2 Pen MIC P8P 2
pattern Strain 13-lact. (~g/ml) pattern
E T1 '" 0,03 A1
E T2 '" 0,03 A1
83 T3 '" 0,03 A1
A2 T4 '" 0,03 A1
C2 T5 '" 0,03 A1
C2 T6 0,125 81
A2 T7 0,125 A2
E T8 0,125 C1
C4 T9 0,125 A1
83 T10 0,125 D
A1 T11 0,125 C1
E T12 1,0 E








• Penicillin was combined with clavulanic acid (4 ~g/ml) for isolates producing ~-Iactamases.
~-Iact. ~ ~-Iactamase production; Pen ~ penicillin; NO ~ not determined, strain P21 was no longer viable.
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Table 11. Details of the N. gonorrhoeae isolates from Botswana and Namibia
Botswana (N =15)
Pen MIC Pen + PBP 2 Tet MIC tetM
Strain 13-lact. (~g/ml) clav' pattern (~g/ml) genet
B1 + > 128 2,0 E 4,0
B2 + > 128 '" 0,06 C1 0,5
B3 + > 128 2,0 E 4,0
B4 + > 128 1,0 E 128 +
B5 + > 128 '" 0,06 0 4,0
B6 + > 128 1,0 E > 128 +
B7 + 128 0,125 0 8,0
B8 1,0 E 128 +
B9 + 64 0,125 0 4,0
B10 + 64 '" 0,06 C2 1,0
B11 0,125 A1 4,0
B12 1,0 E > 128 +
B13 1,0 E > 128 +
B14 1,0 E 64 +
B15 2,0 E > 128 +
• Penicillin was combined with clavulanic acid (4 ~g/ml) for isolates producing ~-Iactamases.
t American-type tetM gene.
~-Iact. = ~-Iactamase production; Pen = penicillin; Tet = tetracycline.
Namibia (N =4)
Pen MIC Pen + PBP 2 Tet MIC tetM
Strain 13-lact. (~g/ml) c1av' pattern ~g/ml) genet
N1 + 32 0,5 E > 128 +
N2 + 4 0,125 E 16 +
N3 + >4 '" 0,03 C1 32 +
N4 + 16 0,5 E 128 +







N. cinerea gene block (Fig. 2). The group C1 pattern lacks
the 309 bp fragment because of an extra Hpall restriction
site at nucleotide 1594, C1 appears to have a small block of
N. flavescens DNA, while C2 and C3 had fewer restriction
sites over the terminal region (Fig. 2); pattern C4 found with
one strain only is similar to C1 with additional bands of
questionable significance. The plasmid profiles of the high-
level tetracycline-resistant isolates (MIC;;' 16 !-Ig/ml) from
Botswana are shown in Fig. 3. All the strains possessed the
25,2 MDaconjugative plasmid as did the four Namibian
isolates (not shown). In some isolates (6/11) the tetM
conjugative plasmid was seen in association with 3,4 MDa
13-lactamase plasmids. All the isolates harboured the cryptic
2,6 MDa plasmid; however, the 24,5 MDa conjugative
plasmid was not observed. PCR products of the tetM gene
of the predicted size 765 bp,'D were obtained from all the
isolates with tetracycline MICs of ;;. 16 !-Ig/m!. A PCR
product was not demonstrable with DNA from a
tetracycline-susceptible strain (MIC 0,25 !-Ig/ml), or with the
DNA from 3 Botswana isolates where the tetracycline MICs
ranged between 4 and 8 !Jg/m!. Hpall restriction patterns of
tetM genes are shown in Fig. 4 and can be seen to be of the
American type. All the strains from Botswana and Namibia
with tetracycline MICs ;;. 16 !-Ig/ml were found to contain the
American-type tetM resistance gene (Table 11).
Discussion
Hpall penA gene fingerprinting and tetM gene restriction
analysis appears to be useful in characterising these genes
in N. gonorrhoeae isolates. The penA fingerprints of groups
D and E are of interest because of their similarity to
previously described sequences;·21 and groups Band C
appear more individual, especially in respect of restriction
site alterations upstream of the terminal 450 bp area.
However, whether any clonal relationships exist between
strains assigned to a specific group requires further studies.
Fig. 1. Hpall PBP 2 gene fingerprint groups. (A) complete PBP 2
gene fingerprints; (B) transpeptidase domain fingerprints.
Fingerprint groups are given in brackets after each strain.
{A} LANES: 1 - 9 Transvaal strains, LANES: 10 - 14 Botswana
strains, LANES: 15 - 16 Namibia strains, LANES: 17 - 24
Bloemfontein strains, LANES: 25 - 31 Cape strains. LANES: 1, T5
{A1}; 2, T6 {B1}; 3, T2 {A1}; 4, T7 (A2); 5, T8 {C1}; 6, T10 (D); 7, T11
{C1}; 8, T12 (E); 9, T13 (E); 10, B11 (A1); 11, B14 (E); 12, B2 {C1}; 13,
B5 (D); 14, B~O {C2}; 15, N4 (E); 16, N3 (C1); 17, P7 {A1}; 18, P16
{B2}; 19, P12 (A3); 20, P19 (E); 21, P4 {C3}; 22, P27 (D); 23, P20 {C2};
24, P6 (E); 25, C16 {A2}; 26, C3 (B3); 27, C14 (A1); 28, C9 (E); 29, C19
{C1}; 30, C10 {C4}; 31, C18 (C2). (B) LANES: 32, T8 group C1; 33,
T10 group D; 34, T12 group E. Arrows indicate fragments that differ
{either absent or new} from those of group A1.






309 95 45 AI
74 235 95 45 Cl C4
74 C2
45 C3
74 84 291 D
309 140 E
Fig. 2. Hpall~restriction sites in the terminal 450 bp region of the
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Fig. 3. Plasmid profiles of high-level tetracycline-resistant strains
isolated in 80tswana. LANES: 1, MWM Ill; 2, strain 82
tetracycline-susceptible; 3 and 11, American control strain 6418
containing tetM conjugative plasmid; 4,84; 5,813; 6, 815; 7, 86;
8,88; 9,812; 10, 814; 12, control strain E 13-lactamase-positive







1 . 2 3' 4 5 6 7 8 9 1011 12 13
Fig. 4. Hpall restriction patterns of the tetM gene of representative
80tswana and Namibia strains. LANES: 1, MWM V; 2, ~DNA; 3, peR
product unrestricted; 4, Dutch control type tetM gene; 5, American
control type tetM gene; 6, 84; 7, 88; 8,814; 9, 812; 10, N1; 11, 86;
12, N2; 13, 815.
Identification of the American type tetM gene indicates that
the PCR-RFLP method proposed by Ison et al. '° is of value
for epidemiological typing of N. gonorrhoeae isolates that
exhibit high-level tetracycline resistance. Given that the tetM
gene currently present in Botswana and Namibia has now
been identified as the American type, it should prove
interesting to see if the Dutch-type gene is introduced into
the southern African environment or whether the American-
type gene continues to predominate and spread.
The findings of isolates with penicillin MICs 0,125 - 2,0
~g/ml that possessed only Hpall fingerprint pattern E tends
to suggest that pattern E predisposes N. gonorrhoeae
strains to increased resistance. However, four strains with
group E fingerprint patterns were susceptible (MICs ~ 0,03
~g/ml). This type of result is unfortunately consistent with
Neisseria PBP 2 gene analysis: introduction of recognised
gene blocks into N. gonorrhoeae and N. meningitidis penA
genes has occurred, but the full implications of their
presence for development of penicillin resistance are not
completely understood!·'.22 The Asp-345A insert has been
demonstrated in all N. gonorrhoeae strains with MICs ;;.
0,03/0,06 ~g/ml studied to date.3,23 Contributions of PBP 2
insertions and mutations in conjunction with PBP 1 and
permeability alterations have to be evaluated in order to
explain MICs of ;;. 0,125 ~g/ml in the absence of
J3-lactamase production. Decreased susceptibility to
cefoxitin was also seen, with 12 out of 15 strains from
Botswana being associated with Hpall PBP 2 fingerprint
groups 0 and E. Initial stages of reduced susceptibility to
ceftriaxone (MIC range ~ 0,002 - 0,06 ~g/ml) was also
evident in the N. gonorrhoeae isolates studied, and has
been observed in Johannesburg strains."
The results of this study of the high-level tetracycline-
resistant isolates as regards combined penicillin resistance
(chromosomally or plasmid-mediated) are disturbing. The
American type tetM gene has been described in Gabon,
Kenya and Zaire,'5 and now appears to have spread to
southern Africa. The presence of the tetM conjugative
plasmid in neighbouring countries is cause for concern in
South Africa as the usage of tetracy<?line to treat C.
trachomatis may still select for high-level tetracycline-
resistant N. gonorrhoeae strains in the future. The presence
of conjugative plasmids are a threat as they are capable of
mobilising nonconjugative resistance plasmids and rapidly
disseminating them throughout populations. In the present
study, in 6 of the 11 high-level tetracycline-resistant isolates
the tetM conjugative plasmid was seen to coexist with the
African-type (3,4 MDa) J3-lactamase plasmids. Of even
greater concern, the presence of tetM genes may facilitate.
the establishment of additional resistance determinants as
N. gonorrhoeae is naturally transformable and the 25,2 MDa
plasmid has been shown to have a wider host range than
the 24,5 MDa conjugative plasmid.25
The spread of penicillin and tetracycline resistance genes
(Namibia and Botswana) has recently lead to the
introduction of more expensive antibiotics to treat
gonococcal infections. Treatment costs per patient have
escalated and as exposure increases, continued monitoring
of resistance development to ceftriaxone and ciprofloxacin is
vital, since these drugs are likely to become ineffective. This
would inevitably result in further rises in antibiotic cost,
problems in obtaining effective/non-toxic antibiotics and,
with the loss of empirical antibiotic cover to treat
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gonococcal infections, the added expense of culture and
susceptibility testing.
The study emphasises the importance of determining the
location (chromosomal or plasmid) of antibiotic resistance
genes and the need to characterise these genes individually.
Numerous genetic techniques are available to subtype
bacterial species. The cost-effectiveness of each method
and its relevance need to be established before such
techniques are used in epidemiological studies. By applying
genetic techniques, resistance genes can be characterised,
origins of new resistance determinants can be identified
and, hopefully, dissemination can be contained.
This study was supported by grants to L. J. Chalkley from the
South African Medical Research Council.
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CLINICAL GUIDELINES
Chronic fatigue syndrome
Committee for Science and Education, Medical
Association of South Africa
Objective. To acknowledge the dinical syndrome chronic
fatigue syndrome (CFS) and outline the diagnostic criteria
and reasonable management.
Outcomes. Attempt at containment of treatmentcost
and improvement of the quality of care of patients with
CFS.
Evidence. Delphi-type commentary from 20 expert
clinicians and appropriate organisations. Umiteq literature
survey. ,-
Values. To clarify the reasonable management of CFS
amid conflicting clinical opinion on a condition qf concern
to patients, funders and doctors, An adaptation:of an
existing guideline was sent to organisations and
individuals for comment. Comments received were
included in this guideline where possible.
Benefits, harms and costs. To acknowledge a clinical
syndrome with a reasonable approach to management
considering the cost implications. No cost analysis was
done.
Recommendations. To recommend the following:
(I) diagnostic criteria for CFS; (il) potential differential
diagnoses and possible investigations; and
(iil) management protocol.
Validation. The draft guidelines were subjected to
external review by individual doctors who are
acknowledged CFS treaters, doctor groups and the patient
support group. There were major disputes about the
content, with the responses falling into two groups: those
who do not believe CFS is a distinguishable illness, and
those who do.
Developer and funding. The Committee for Science and
Education, Medical Association of South Africa,
Endorsements. Medical Association of South Africa and
national health care organisations (see list at the end of
the document).
S Atr Med J 1995; 85: 780-782.
Synonyms
Major controversy surrounds the name of the syndrome.
In medical circles the preferred term is chronic fatigue
Committee Members: E. M. Barker (Chairperson), B, M. de Bruijn,
E. J, Immelman, D. G. C. Presbury, A. D. P. v<;In den Berg, D. A. Green,
V. J. Pinkney-Atkinson
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